ETV

DRUG5 trials

Sponsors

Sunshine Lake Pharma Co., Ltd., Tongji Hospital, Assembly Biosciences, Janssen Research & Development, LLC

Conditions

Chronic HBV InfectionChronic Hepatitis BChronic Hepatitis bHepatitis B, Chronic

Phase 1

A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects

CompletedNCT03662568

Sunshine Lake Pharma Co., Ltd.Chronic Hepatitis B

Start: 2018-06-26End: 2019-06-10Updated: 2019-10-09

Phase 2

Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

CompletedNCT04147208

Sunshine Lake Pharma Co., Ltd.Chronic HBV Infection

Start: 2019-02-28End: 2023-09-14Updated: 2024-06-21

Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)

Tongji HospitalChronic Hepatitis b

Start: 2020-01-01End: 2021-06-30Target: 30Updated: 2019-12-19

A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection

TerminatedNCT04781647

Assembly BiosciencesChronic Hepatitis B

Start: 2021-02-18End: 2022-12-02Updated: 2023-10-06

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection

TerminatedNCT05005507

Janssen Research & Development, LLCHepatitis B, Chronic

Start: 2021-11-03End: 2021-12-29Updated: 2024-03-06

Related Papers

Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial

Journal of Infection2025-02-212 citations